BRKB

478.79

-0.61%↓

BRKA.US

717,969.4

-0.62%↓

JPM

292.31

+0.5%↑

V

304.7

-0.3%↓

MA

499.57

-0.63%↓

BRKB

478.79

-0.61%↓

BRKA.US

717,969.4

-0.62%↓

JPM

292.31

+0.5%↑

V

304.7

-0.3%↓

MA

499.57

-0.63%↓

BRKB

478.79

-0.61%↓

BRKA.US

717,969.4

-0.62%↓

JPM

292.31

+0.5%↑

V

304.7

-0.3%↓

MA

499.57

-0.63%↓

BRKB

478.79

-0.61%↓

BRKA.US

717,969.4

-0.62%↓

JPM

292.31

+0.5%↑

V

304.7

-0.3%↓

MA

499.57

-0.63%↓

BRKB

478.79

-0.61%↓

BRKA.US

717,969.4

-0.62%↓

JPM

292.31

+0.5%↑

V

304.7

-0.3%↓

MA

499.57

-0.63%↓

Search

The Western Union Co.

Atidarymo kaina

SektoriusFinansų sektorius

9.2 -0.33

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

9.07

Max

9.21

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-25M

114M

Pardavimai

-27M

1B

P/E

Sektoriaus vid.

6.243

54.048

Dividendų pajamingumas

9.86

Pelno marža

11.372

Darbuotojai

9,600

EBITDA

-13M

230M

Rekomendacijos

By TipRanks

Rekomendacijos

Parduoti

12 mėnesių prognozė

-2.07% downside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

9.86%

4.84%

Kitas uždarbis

2026-04-22

Kitas dividendų mokėjimo data

2026-03-31

Kita Ex Dividend data

2026-06-15

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-84M

3B

Ankstesnė atidarymo kaina

9.53

Ankstesnė uždarymo kaina

9.2

Naujienos nuotaikos

By Acuity

26%

74%

52 / 441 reitingas Finance

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

The Western Union Co. Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-23 23:47; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

2026-03-23 22:55; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

2026-03-23 21:51; UTC

Įsigijimai, susijungimai, perėmimai

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

2026-03-23 23:59; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-23 23:59; UTC

Rinkos pokalbiai

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

2026-03-23 23:50; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

2026-03-23 23:37; UTC

Rinkos pokalbiai

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Equities Roundup: Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

2026-03-23 22:40; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

2026-03-23 22:23; UTC

Rinkos pokalbiai

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

2026-03-23 22:22; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

2026-03-23 22:18; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

2026-03-23 22:15; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

2026-03-23 22:08; UTC

Rinkos pokalbiai

Ebos Needs to Reset Its Gearing Targets -- Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

2026-03-23 21:10; UTC

Svarbiausios naujienos

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

2026-03-23 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai
Uždarbis
Svarbiausios naujienos

Basic Materials Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

The Western Union Co. Prognozė

Kainos tikslas

By TipRanks

-2.07% į apačią

12 mėnesių prognozė

Vidutinis 9 USD  -2.07%

Aukščiausias 10 USD

Žemiausias 7 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines The Western Union Co. kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Parduoti

9 ratings

0

Pirkti

4

Laikyti

5

Parduoti

Techninis įvertinimas

By Trading Central

9.72 / 10.0901Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

52 / 441 reitingas Finansų sektorius

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę The Western Union Co.

The Western Union Company is a provider of money movement and payment services. The Company’s segments include Consumer-to-Consumer and Business Solutions. The Consumer-to-Consumer operating segment facilitates money transfers that are sent from retail agent locations worldwide or through Websites and mobile devices, including digital money transfer services. Its money transfer service is provided through one interconnected global network and these services are available for international cross-border transfers and, in certain countries, intra-country transfers. The Business Solutions segment facilitates payment and foreign exchange solutions, primarily cross-border, cross-currency transactions, for small and medium-sized enterprises, and other organizations and individuals.
help-icon Live chat